AEMD Aethlon Medical


Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On September 15, 2021, Aethlon Medical, Inc. (the “Company”) held its virtual 2021 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders considered the two proposals listed below, each of which was described in the Proxy Statement. The voting results are set forth below.

Proposal 1. Elect five members of the Board of Directors. All of the nominees were elected.

NameVotes ForVotes AgainstAbstentionsBroker Non-Votes
Edward G. Broenniman7,480,266143,13519,4592,506,013
Guy F. Cipriani7,372,780250,17819,9022,506,013
Charles J. Fisher, Jr., M.D.7,523,207110,1239,5302,506,013
Sabrina Martucci Johnson7,283,551339,15620,1532,506,013
Chetan S. Shah, M.D.7,512,445116,09714,3182,506,013

Proposal 2. Ratify the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for its fiscal year ending March 31, 2022. The resolution was approved.

Votes ForVotes AgainstAbstentionsBroker Non-Votes

No adjournment of the Annual Meeting was necessary.